medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-8-8-12medalphabet-2009Research ArticleСтатьиЭмпирическая и долговременная терапия тазовой боли, связанной с эндометриозомEmpirical and long-term therapy for endometriosis-associated pelvic painhttps://orcid.org/0000-0001-5541-3767КузнецоваИ. В.KuznetsovaI. V.

Кузнецова Ирина Всеволодовна - доктор медицинских наук, профессор, советник директора.

Москва.

Kuznetsova Irina V. - DM Sci, prof., advisor to director.

Moscow.

ms.smith.ivk@gmail.comНаучный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени В.И. КулаковаРоссияScientific Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. KulakovaRussian Federation20211106202108Современная гинекология (1)812Copyright © Кузнецова И.В., 20212021Кузнецова И.В.Kuznetsova I.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2009

Эндометриоз является распространенным заболеванием, диагностика и терапия которого по-прежнему остаются предметом дискуссий Один из главных симптомов эндометриоза - тазовая боль представляет особую проблему в связи со сложностями выявления причины и отсутствием достаточного эффекта от хирургического и медикаментозного лечения. В обзоре литературы представлены современные данные о распространенности, клинической характеристике и методах индивидуального подбора терапии у пациенток с тазовой болью установленно или предположительно ассоциированной с эндометриозом.

Endometriosis is a common disease, the diagnosis and treatment of which is still a matter of debate. One of the main symptoms of endometriosis -pelvic pain is a particular problem due to the difficulties in identifying the cause and the lack of sufficient effect from surgical and medical treatment. The literature review presents current data on the prevalence, clinical characteristics and methods of individualized therapy in patients with pelvic pain established or presumably associated with endometriosis.

эндометриоздисменореядиспареунияхроническая тазовая больпрогестиныдиеногесткомбинированные оральные контрацептивыendometriosisdysmenorrheadyspareuniachronic pelvic painprogestinsdienogestcombined oral contraceptivesReferencesKlein S, D'Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? A prospective Belgian study. Reprod Biomed Online. 2014; 28 (1): 116-124. DOI: 10.1016/j.rbmo.2013.09.020.Klein S, D'Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? A prospective Belgian study. Reprod Biomed Online. 2014; 28 (1): 116-124. DOI: 10.1016/j.rbmo.2013.09.020.Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012; 27 (5): 1292-1299. DOI: 10.1093/humrep/des073.Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012; 27 (5): 1292-1299. DOI: 10.1093/humrep/des073.Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10 (5): 261-275. DOI: 10.1038/nrendo.2013.255.Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10 (5): 261-275. DOI: 10.1038/nrendo.2013.255.Soliman AM, Coyne KS, Zaiser E, Castelli-Haley J, Fuldeore MJ. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosom Obstet Gynaecol. 2017; 38 (4): 238-248. DOI: 10.1080/0167482X.2017.1289512.Soliman AM, Coyne KS, Zaiser E, Castelli-Haley J, Fuldeore MJ. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosom Obstet Gynaecol. 2017; 38 (4): 238-248. DOI: 10.1080/0167482X.2017.1289512.Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017; 209: 3-7. DOI: 10.1016/j.ejogrb.2016.04.021.Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017; 209: 3-7. DOI: 10.1016/j.ejogrb.2016.04.021.Powell J. The approach to chronic pelvic pain in the adolescent. Obstet Gynecol Clin North Am. 2014; 41 (3): 343-355. DOI: 10.1016/j.ogc.2014.06.001.Powell J. The approach to chronic pelvic pain in the adolescent. Obstet Gynecol Clin North Am. 2014; 41 (3): 343-355. DOI: 10.1016/j.ogc.2014.06.001.Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest. 2017; 82 (5): 453-461. DOI: 10.1159/000452660.Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest. 2017; 82 (5): 453-461. DOI: 10.1159/000452660.Singh S, Soliman AM, Rahal Y, Robert C, Defoy I, Nisbet P, Leyland N. Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30 000 Women. J Obstet Gynaecol Can. 2020; 42 (7): 829-838. DOI: 10.1016/j.jogc.2019.10.038.Singh S, Soliman AM, Rahal Y, Robert C, Defoy I, Nisbet P, Leyland N. Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30 000 Women. J Obstet Gynaecol Can. 2020; 42 (7): 829-838. DOI: 10.1016/j.jogc.2019.10.038.Эндометриоз: диагностика, лечение и реабилитация: Федеральные клинические рекомендации по ведению больных. М.: МЗ РФ, 2016.Endometriosis: Diagnosis, Treatment and Rehabilitation: Federal Clinical Guidelines for Patient Management. Moscow: Ministry of Health of Russian Federation, 2016.Muzii L, Marana R, Angioli R, Bianchi A, Cucinella G, Vignali M, Benedetti Panici P, Busacca M. Histologic analysis of specimens from laparoscopic endometrioma excision performed by different surgeons: does the surgeon matter? Fertil Steril. 2011; 95 (6): 2116-2119. DOI: 10.1016/j.fertnstert.2011.02.034.Muzii L, Marana R, Angioli R, Bianchi A, Cucinella G, Vignali M, Benedetti Panici P, Busacca M. Histologic analysis of specimens from laparoscopic endometrioma excision performed by different surgeons: does the surgeon matter? Fertil Steril. 2011; 95 (6): 2116-2119. DOI: 10.1016/j.fertnstert.2011.02.034.Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, As-Sanie S. Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain. Obstet Gynecol 2016; 127 (6): 1045-1053.Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, As-Sanie S. Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain. Obstet Gynecol 2016; 127 (6): 1045-1053.Gubbels AL, Li R, Kreher D, Mehandru N, Castellanos M, Desai NA, Hibner M. Prevalence of occult microscopic endometriosis in clinically negative peritoneum during laparoscopy for chronic pelvic pain. Int J Gynaecol Obstet. 2020; 151 (2): 260-266. DOI: 10.1002/ijgo.13303.Gubbels AL, Li R, Kreher D, Mehandru N, Castellanos M, Desai NA, Hibner M. Prevalence of occult microscopic endometriosis in clinically negative peritoneum during laparoscopy for chronic pelvic pain. Int J Gynaecol Obstet. 2020; 151 (2): 260-266. DOI: 10.1002/ijgo.13303.Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215 (5): 589.e1-589.e6. DOI: 10.1016/j.ajog.2016.05.029.Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215 (5): 589.e1-589.e6. DOI: 10.1016/j.ajog.2016.05.029.Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, Chapron C. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod. 2012; 27: 3294-3303.Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, Chapron C. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod. 2012; 27: 3294-3303.Sugita A, Iwase A, Goto M, et al. One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? Fertil Steril. 2013; 100 (2): 516-522.e3. DOI: 10.1016/j.fertnstert.2013.03.032.Sugita A, Iwase A, Goto M, et al. One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? Fertil Steril. 2013; 100 (2): 516-522.e3. DOI: 10.1016/j.fertnstert.2013.03.032.Ferrero S, Scala C, Racca A, Calanni L, Remorgida V, Venturini PL, Leone Roberti Maggiore U. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril. 2015; 103 (5): 1236-1243. DOI: 10.1016/j.fertnstert.2015.01.032.Ferrero S, Scala C, Racca A, Calanni L, Remorgida V, Venturini PL, Leone Roberti Maggiore U. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril. 2015; 103 (5): 1236-1243. DOI: 10.1016/j.fertnstert.2015.01.032.Dunselman GA, Vermeulen N, Becker C, et al; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29 (3): 400-412. DOI: 10.1093/humrep/det457.Dunselman GA, Vermeulen N, Becker C, et al; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29 (3): 400-412. DOI: 10.1093/humrep/det457.Sieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescentstriking early to limit suffering: A narrative review. Neurosci Biobehav Rev. 2020; 108: 866-876. DOI: 10.1016/j.neubiorev.2019.12.004.Sieberg CB, Lunde CE, Borsook D. Endometriosis and pain in the adolescentstriking early to limit suffering: A narrative review. Neurosci Biobehav Rev. 2020; 108: 866-876. DOI: 10.1016/j.neubiorev.2019.12.004.Антоненко М. В., Сапрыкина О. А. Использование агонистов гонадотропных рилизинг-гормонов в терапии эндометриоза. Эффективная фармакотерапия. Акушерство и гинекология. 2012; 1: 34-35.Antonenko M. V., Saprykina O. A. The use of gonadotropic-releasing hormone agonists in the treatment of endometriosis. Effective pharmacotherapy. Obstetrics and gynecology. 2012; 1: 34-35.Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update. 2020 Jun 18; 26 (4): 565-585. DOI: 10.1093/humupd/dmaa009.Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update. 2020 Jun 18; 26 (4): 565-585. DOI: 10.1093/humupd/dmaa009.Choi J, Jo M, Lee E, Lee DY, Choi D. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Mol Hum Reprod. 2020; 26 (1): 30-39. DOI: 10.1093/molehr/gaz064.Choi J, Jo M, Lee E, Lee DY, Choi D. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Mol Hum Reprod. 2020; 26 (1): 30-39. DOI: 10.1093/molehr/gaz064.Mita S, Shimizu Y, Sato A, Notsu T, Imada K, Kyo S. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertil Steril. 2013; 101 (2): 595–601. DOI: 10.1016/j.fertnstert.2013.10.038.Mita S, Shimizu Y, Sato A, Notsu T, Imada K, Kyo S. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertil Steril. 2013; 101 (2): 595–601. DOI: 10.1016/j.fertnstert.2013.10.038.Miyashita M, Koga K, Takamura M, et al. Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecol Endocrinol 2014; 30 (9): 644-648. DOI: 10.3109/09513590.2014.911279.Miyashita M, Koga K, Takamura M, et al. Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecol Endocrinol 2014; 30 (9): 644-648. DOI: 10.3109/09513590.2014.911279.Takeuchi A, Koga K, Miyashita M, et al. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016; 207: 157-161. DOI: 10.1016/j.ejogrb.2016.10.053.Takeuchi A, Koga K, Miyashita M, et al. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016; 207: 157-161. DOI: 10.1016/j.ejogrb.2016.10.053.Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, Bono Y, Kyo S. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015; 147: 103-110. DOI: 10.1016/j.jsbmb.2014.12.008.Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, Bono Y, Kyo S. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015; 147: 103-110. DOI: 10.1016/j.jsbmb.2014.12.008.Grandi G, Mueller M, Bersinger NA, Cagnacci A, Volpe A, McKinnon B. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res. 2016; 65 (3): 183-192. DOI: 10.1007/s00011-015-0909-7.Grandi G, Mueller M, Bersinger NA, Cagnacci A, Volpe A, McKinnon B. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res. 2016; 65 (3): 183-192. DOI: 10.1007/s00011-015-0909-7.Mabrouk M, Paradisi R, Arena A, Del Forno S, Matteucci C, Zannoni L, Caprara G, Seracchioli R. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. Gynecol Endocrinol. 2018; 34 (5): 399-403. DOI: 10.1080/09513590.2017.1405932.Mabrouk M, Paradisi R, Arena A, Del Forno S, Matteucci C, Zannoni L, Caprara G, Seracchioli R. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. Gynecol Endocrinol. 2018; 34 (5): 399-403. DOI: 10.1080/09513590.2017.1405932.Del Forno S, Mabrouk M, Arena A, Mattioli G, Giaquinto I, Paradisi R, Seracchioli R. Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? Eur J Obstet Gynecol Reprod Biol. 2019; 238: 120-124. DOI: 10.1016/j.ejogrb.2019.04.010.Del Forno S, Mabrouk M, Arena A, Mattioli G, Giaquinto I, Paradisi R, Seracchioli R. Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? Eur J Obstet Gynecol Reprod Biol. 2019; 238: 120-124. DOI: 10.1016/j.ejogrb.2019.04.010.Kitajima M, Matsumoto K, Murakami N, Harada A, Kitajima Y, Masuzaki H, Miura K. Ovarian reserve after three-step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study. Reprod Med Biol. 2020; 19 (4): 425-431. DOI: 10.1002/rmb2.12349.Kitajima M, Matsumoto K, Murakami N, Harada A, Kitajima Y, Masuzaki H, Miura K. Ovarian reserve after three-step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study. Reprod Med Biol. 2020; 19 (4): 425-431. DOI: 10.1002/rmb2.12349.Angioni S, Pontis A, Malune ME, Cela V, Luisi S, Litta P, Vignali M, Nappi L. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020; 36 (1): 84-86. DOI: 10.1080/09513590.2019.1640674.Angioni S, Pontis A, Malune ME, Cela V, Luisi S, Litta P, Vignali M, Nappi L. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020; 36 (1): 84-86. DOI: 10.1080/09513590.2019.1640674.Muzii L, Galati G, Di Tucci C, Di Feliciantonio M, Perniola G, Di Donato V, Benedetti Panici P, Vignali M. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020; 36 (1): 81-83. DOI: 10.1080/09513590.2019.1640199.Muzii L, Galati G, Di Tucci C, Di Feliciantonio M, Perniola G, Di Donato V, Benedetti Panici P, Vignali M. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020; 36 (1): 81-83. DOI: 10.1080/09513590.2019.1640199.Тихонова Е. С. Медицинские и социальные аспекты генитального эндометриоза: Автореф. дис. ... канд. мед. наук. М., 2013; 26 с.Tikhonova E. S. Medical and social aspects of genital endometriosis: Author's abstract. dis. ... Cand. med. sciences. M., 2013; 26 p.Кузнецова И. В. Эндометриоз и тазовая боль: что мы лечим? О природе болевого синдрома при эндометриозе и возможностях терапии. Status Praesens. Гинекология, акушерство, бесплодный брак. 2015; 1 (27): 50-54.I. V. Kuznetsova Endometriosis and Pelvic Pain: What Do We Treat? On the nature of pain in endometriosis and the possibilities of therapy. Status Praesens. Gynecology, obstetrics, sterile marriage. 2015; 1 (27): 50-54.Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014; 101 (4): 927-935. DOI: 10.1016/j.fertnstert.2014.02.012.Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014; 101 (4): 927-935. DOI: 10.1016/j.fertnstert.2014.02.012.Caruso S, Iraci M, Cianci S, Fava V, Casella E, Cianci A. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 pg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest. 2016; 39 (8): 923-931. DOI: 10.1007/s40618-016-0460-6.Caruso S, Iraci M, Cianci S, Fava V, Casella E, Cianci A. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 pg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest. 2016; 39 (8): 923-931. DOI: 10.1007/s40618-016-0460-6.Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A, Fedele L. Oral contraceptives and risk of endometriosis: a systematic review and me-ta-analysis. Hum Reprod Update. 2011; 17 (2): 159-170. DOI: 10.1093/humupd/dmq042.Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A, Fedele L. Oral contraceptives and risk of endometriosis: a systematic review and me-ta-analysis. Hum Reprod Update. 2011; 17 (2): 159-170. DOI: 10.1093/humupd/dmq042.Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaoui G, Goffinet F, de Ziegler D. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011; 26 (8): 2028-2035. DOI: 10.1093/humrep/der156.Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaoui G, Goffinet F, de Ziegler D. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011; 26 (8): 2028-2035. DOI: 10.1093/humrep/der156.Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018; 51: 68-91. DOI: 10.1016/j.bpobgyn.2018.01.015.Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018; 51: 68-91. DOI: 10.1016/j.bpobgyn.2018.01.015.

The authors declare that there are no conflicts of interest present.